K142664 is an FDA 510(k) clearance for the URight Hemoglobin A1c system, FORA A1c System. This device is classified as a Assay, Glycosylated Hemoglobin (Class II - Special Controls, product code LCP).
Submitted by Taidoc Technology Corporation (New Taipei City, TW). The FDA issued a Cleared decision on January 29, 2016, 498 days after receiving the submission on September 18, 2014.
This device falls under the Chemistry FDA review panel. Regulated under 21 CFR 864.7470.
| 510(k) Number | K142664 FDA.gov |
| FDA Decision | Cleared Substantially Equivalent - Traditional 510(k) (SESE) |
| Date Received | September 18, 2014 |
| Decision Date | January 29, 2016 |
| Days to Decision | 498 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
| Product Code | LCP — Assay, Glycosylated Hemoglobin |
| Device Class | Class II - Special Controls |
| CFR Regulation | 21 CFR 864.7470 |